Mounjaro peak time: when tirzepatide is most active in your body

What the SmPC data says about tirzepatide's peak concentration

The Mounjaro Summary of Product Characteristics, published on the electronic Medicines Compendium, reports that after a single subcutaneous injection tirzepatide reaches peak plasma concentration (Tmax) between 24 and 72 hours, with a median of approximately 48 hours. This is determined by the rate at which the medicine is absorbed from the subcutaneous tissue into the bloodstream after injection into the abdomen, thigh or upper arm.

This is not a short spike. Tirzepatide has a terminal half-life of around five days, which is what makes a once-weekly injection schedule pharmacologically coherent. The concentration climbs to its peak in the first two days, then falls gradually over the remaining five or six days before the next injection brings it back up. After four weeks of weekly dosing, the medicine reaches a steady-state level, meaning the troughs between doses are higher than they were at the start. Understanding how tirzepatide works as a dual GIP and GLP-1 receptor agonist helps explain why this sustained presence matters, both receptors need consistent activation to regulate appetite and gastric emptying effectively.

The eMC SmPC for Mounjaro is the definitive reference for the exact pharmacokinetic figures; if your prescriber or pharmacist wants the numbers, that's where they'll look.

Why the peak matters for side effects (especially in the early weeks

A question our prescribers hear most weeks: "I felt fine after the injection but felt sick two days later) is that normal?" Yes, and the pharmacokinetics explain it. Nausea, indigestion and other GI symptoms that people commonly notice with Mounjaro tend to follow the rising drug-concentration curve rather than appearing immediately at injection. So symptoms that start or peak around 24–48 hours after the dose are consistent with the medicine behaving exactly as expected.

This pattern tends to be most pronounced at the start of treatment and after each dose increase, when the body is adjusting to a higher peak level. The timeline for Mounjaro to produce noticeable effects is shaped partly by this same pharmacokinetic arc. As weeks pass and steady-state concentration builds, many people find the post-peak GI window becomes less pronounced. Symptoms that are severe, prolonged or include intense stomach pain should always prompt contact with your prescriber rather than waiting it out. The NHS patient information for tirzepatide outlines which symptoms warrant medical attention and is worth reading alongside the Patient Information Leaflet supplied with your pen.

Injection site, rotation and timing within the day do not meaningfully alter the peak concentration or the Tmax window according to the SmPC data.

Steady state and what changes after four weeks

The first four weeks of Mounjaro treatment are pharmacologically different from what follows. At the 2.5 mg starting dose, each injection is building toward a steady state rather than maintaining one. Once steady state is reached, the effective drug exposure across the week is higher and more consistent than in week one, even at the same dose. This is partly why the appetite-suppressing effect can feel more sustained as treatment progresses, and why the full clinical effect of Mounjaro is not typically assessed until several weeks in.

When a dose is increased, the cycle resets: the body moves through a new accumulation phase toward the higher dose's steady state. For a detailed look at when Mounjaro peaks across the treatment journey, including how dose changes affect that window, our dedicated page covers the stages clearly. The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed participants for 72 weeks and the most significant average weight reductions, around 20–21% at the 15 mg dose, were observed over that sustained period, reflecting months of maintained steady-state exposure rather than any single peak event.

If you're trying to time activities, travel or meals around your injection day, the honest answer is that the peak window is real but the whole-week exposure is what drives treatment. There's no strong clinical rationale for timing injections to specific hours of the day. For practical questions about how and where to administer each injection, the technique guidance is worth reviewing regardless of timing preferences.

Cost context and how to get started

Understanding the pharmacokinetics is useful, but Mounjaro is only available with a prescription following clinical assessment. It is not available over the counter. If you're weighing up whether private treatment makes sense given the costs involved, our Mounjaro cost page sets out what a legitimate private prescription includes, and what headline prices sometimes leave out. For anyone considering treatment, starting a free consultation with our prescribers is the first step. A GPhC-registered Independent Prescriber reviews your answers the same day; no algorithms, no queues. Once clinically approved, treatment is dispatched the same day (for orders placed by 12pm, Monday to Friday) and delivered free the next working day by DPD in plain packaging.